Cargando…
DNA Methylation in Circulating Tumour DNA as a Biomarker for Cancer
Free circulating DNA, which is thought to be derived from the primary tumour, can be detected in the blood of patients with cancer. Detection of genetic and epigenetic alteration in this tumour DNA offers a potential source of development of prognostic and predictive biomarkers for cancer. One such...
Autores principales: | Board, Ruth E, Knight, Lucy, Greystoke, Alastair, Blackhall, Fiona H, Hughes, Andrew, Dive, Caroline, Ranson, Malcolm |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2717819/ https://www.ncbi.nlm.nih.gov/pubmed/19662228 |
Ejemplares similares
-
Multi-level evidence that circulating CK18 is a biomarker of tumour burden in colorectal cancer
por: Greystoke, A, et al.
Publicado: (2012) -
A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker
por: Khoja, L, et al.
Publicado: (2012) -
Genetic profiling of tumours using both circulating free DNA and circulating tumour cells isolated from the same preserved whole blood sample
por: Rothwell, Dominic G., et al.
Publicado: (2015) -
Circulating tumour DNA — looking beyond the blood
por: Tivey, Ann, et al.
Publicado: (2022) -
Assessment of circulating biomarkers for potential pharmacodynamic utility in patients with lymphoma
por: Greystoke, A, et al.
Publicado: (2011)